Alirocumab
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Alirocumab is used to treat atherosclerosis and hypercholesterolemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $341 million on Alirocumab across 443,000 claims for 92,000 beneficiaries.
Alirocumab is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $257.73 to $258.02 per ML — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$257.73 – $258.02
per ML
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ALIROCUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PRALUENT 150 MG/ML PEN | $258.0245 per ML | 0.00% |
PRALUENT 75 MG/ML PEN | $257.7315 per ML | +0.03% |
Frequently Asked Questions
What is Alirocumab used to treat?
Alirocumab is used to treat atherosclerosis and hypercholesterolemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Alirocumab?
In 2024, Medicare Part D spent $341 million on Alirocumab across 443,000 claims for 92,000 beneficiaries.
How many Alirocumab products are on the market?
The Alirocumab drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Alirocumab?
NADAC reference prices for Alirocumab range from $257.7315 to $258.0245 per ML — a 0% difference between cheapest and most expensive.
Which manufacturers make Alirocumab?
1 manufacturer lists Alirocumab in NADAC. Ranked by number of NDCs, the largest are Regeneron Pharmaceuticals, Inc. (2).
How has the price of Alirocumab changed recently?
Over the past 7 days, 1 Alirocumab NDC rose and 0 fell, with a market-wide average change of +0.0%.